Development of monoclonal antibody-mediated interventions to combat malaria
$298,596N43FY2022AINIH
Sanaria, Inc., Rockville MD
Investigators
Abstract
This contract is to provide proof of concept studies for the development of a monoclonal antibody to combat P. falciparum malaria.
View original record on NIH RePORTER →